{
  "paper_id": "PMC10242428",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242428/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.  Conceptual Demonstration of the Autoregressive Integrated Moving Average (ARIMA) Model.",
      "caption": "The vertical blue dotted line indicates the onset of the COVID-19 pandemic.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/302a7c636d00/jamanetwopen-e2316642-g001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/302a7c636d00/jamanetwopen-e2316642-g001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/302a7c636d00/jamanetwopen-e2316642-g001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/302a7c636d00/jamanetwopen-e2316642-g001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "zoi230506f1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/302a7c636d00/jamanetwopen-e2316642-g001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10242428/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/302a7c636d00/jamanetwopen-e2316642-g001.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.  Visit Rates by Treatment Type During the Prepandemic (March 2019 to February 2020) and Pandemic (March 2020 to February 2021) Periods.",
      "caption": "A to C, Actual in-person, forecasted (counterfactual) in-person, and telemedicine visit rates for oral therapies (A), outpatient infusion treatments (B), and inpatient infusion treatments (C). The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/cdac06e9e015/jamanetwopen-e2316642-g002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/cdac06e9e015/jamanetwopen-e2316642-g002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/cdac06e9e015/jamanetwopen-e2316642-g002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/cdac06e9e015/jamanetwopen-e2316642-g002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "zoi230506f2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/cdac06e9e015/jamanetwopen-e2316642-g002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC10242428/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/574c/10242428/cdac06e9e015/jamanetwopen-e2316642-g002.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1 demonstrates a conceptual model of the ARIMA method.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Months when the observed rates exceeded the 95% prediction interval (PI) surrounding the forecasted estimates were deemed to have been statistically significantly affected by the pandemic (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "In-Person Visit Rates\nEarly pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The vertical blue dotted lines indicate the onset of the COVID-19 pandemic; shaded areas indicate the 95% prediction interval.When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Early pandemic months experienced significant reductions in in-person visit rates for oral therapy (March to May 2020) and outpatient infusions (April to May 2020) subgroups over all diseases combined (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "When stratified by disease, patients with multiple myeloma had significant reductions within each treatment type (Figure 3).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        },
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "During this period, in-person visit rates returned to close to nonpandemic rates for many diseases and treatment types (Figure 2 and eTables 4 and 5 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "This trend persisted across all treatment types (Figure 2 and eTable 6 in Supplement 1).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 2,
    "claims_count": 68,
    "images_downloaded": 2,
    "tables_filtered": 40
  }
}